Biological effects of inhibitors of S-adenosylhomocysteine hydrolase

Pharmacology and Therapeutics

Volumn 77, Issue 2, 1998, Pages 115-134

  Chiang, Peter K ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

3 Deaza adenosine; Antivirals; Genes; Methylation; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

ADENOSINE; ADENOSYLHOMOCYSTEINASE; ADENOSYLHOMOCYSTEINASE INHIBITOR; ANTIVIRUS AGENT; HOMOCYSTEINE; HYDROLASE; METHYL GROUP; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CELL DIFFERENTIATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; METHYLATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SCIENCE; TRANSCRIPTION REGULATION;

ADENOSYLHOMOCYSTEINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; BLOOD PRESSURE; CELL DIFFERENTIATION; CYCLIC AMP; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; HYDROLASES; METHYLATION; NUCLEOSIDES;

EID: 0031934077     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00089-2     Document Type: Review

References (178)

1. Aarbakke J., Ueland P. M. Interaction of S-adenosylhomocysteine with isolated rat hepatocytes. Mol. Pharmacol. 19:1981;463-469.
2. Aarbakke J., Miura G. A., Prytz P. S., Bessesen A., Chiang P. K. Effects of 3-deazaadenosine on human promyelocytic HL-60 cells. Eur. Paediatr. Haematol. Oncol. 2:1985;189-192.
3. Aarbakke J., Miura G. A., Prytz P. S., Bessesen A., Slørdal L., Gordon R. K., Chiang P. K. Induction of HL-60 cell differentiation by 3-deaza-(±)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase. Cancer Res. 46:1986;5469-5472.
4. Aiyar V. N., Hershfield M. S. Covalent labelling of ligand binding sites of human placental S-adenosylhomocysteine hydrolase with 8-azido-derivatives of adenosine and cyclic AMP. Biochem. J. 232:1985;643-650.
5. Aksamit R. R., Backlund P. S., Cantoni G. L. Chemotaxis and the synthesis of specific proteins are inhibited by 3-deazaadenosine and other adenosine analogs in a mouse macrophage cell line. J. Biol. Chem. 258:1983;20-23.
6. Backlund P. S. Jr., Carotti D., Cantoni G. L. Effect of the S-adenosylhomocysteine hydrolase inhibitors of 3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and synthesis. Eur. J. Biochem. 160:1986;245-251.
7. Bader J. P., Brown N. R., Chiang P. K., Cantoni G. L. 3-Deaza-adenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology. 89:1978;494-505.
8. Bennett L. L. Jr., Allan P. W., Rose L. M., Comber R. N., Secrist J. A. III Differences in the metabolism and metabolic effects of the carbocyclic adenosine analogs, neplanocin A and aristeromycin. J. Pharmacol. Ther. 29:1986;383-390. a.
9. Bennett L. L. Jr., Bowdon B. J., Allan P. W., Rose L. M. Evidence that the carbocyclic analog of adenosine has different mechanisms of cytotoxicity to cells with adenosine kinase activity and to cells lacking this enzyme. Biochem. Pharmacol. 35:1986;4106-4109. b.
10. Bennett L. L. Jr., Brockman W., Allan P. W., Rose L. M., Shaddix S. C. Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds. Biochem. Pharmacol. 37:1986;1233-1244. c.
11. Benyon R. C., Church M. K., Holgate S. T. IgE-dependent activation of mast cells is not associated with enhanced phospholipid methylation. Biochem. Pharmacol. 35:1986;2535-2544. a.
12. Benyon R. C., Church M. K., Holgate S. T. IgE-dependent activation of human lung mast cells is not associated with increased phospholipid methylation. J. Immunol. 141:1986;954-960. b.
13. Bethin K. E., Cimato T. R., Ettinger M. J. Copper binding to mouse liver S-adenosyl-l-homocysteine hydrolase and the effects of copper on its levels. J. Biol. Chem. 270:1995;20703-20711.
14. Bitonti A. J., Baumann R. J., Jarvi E. T., McCarthy J. R., McCann P. P. Antimalarial activity of 4′,5′-unsaturated 5′-fluoroadenosine mechanism-based inhibitors of S-adenosylhomocysteine hydrolase. Biochem. Pharmacol. 40:1990;601-608.
15. Bodenteich M., Marquez V. E., Hallows W. H., Goldstein B. M. Synthesis and structural determination of (±)-neplanocin F. J. Org. Chem. 57:1991;2071-2076.
16. Borchardt R. T., Keller B. T., Patel-Thombre U. Neplanocin A. a potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells J. Biol. Chem. 259:1984;4353-4358.
17. Borcherding D. R., Narayanan S., Hasboe M., McKee J. G., Keller B. T., Borchardt R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases: 11. Molecular dissections of neplanocin A as potential inhibitors of Sadenosylhomocysteine hydrolase. J. Med. Chem. 31:1989;1729-1738.
18. Braun J., Rosen F. S., Unanue E. R. Capping and adenosine metabolism. genetic and pharmacologic studies J. Exp. Med. 151:1980;174-183.
19. Brown N. D., Miura G. A., Stermer-Cox M. G., Richard M. M., Chiang P. K. Unexpected increase in catecholamines in adrenals of rats treated with 3-deazaadenosine. Biochem. Biophys. Res. Commun. 127:1985;924-928.
20. 4-substituted imidazo- and v-triazolo[4,5-d]pyridazine nucleosides. J. Med. Chem. 36:1993;4113-4120.
21. Cantoni J. L. Biological methylation. selected aspects Annu. Rev. Biochem. 44:1975;435-451.
22. Chen X., Schneller S. W., Ikeda S., Snoeck R., Andrei G., Balzarini J., De Clercq E. Synthesis and antiviral activity of 5′-deoxypyrazofurin. J. Med. Chem. 36:1993;3727-3730.
23. Chiang P. K. Conversion of 3T3-Ll fibroblasts to fat cells by an inhibitor of methylation: effect of 3-deazaadenosine Science. 211:1981;1164-1166.
24. Chiang P. K. S-Adenosylhomocysteine hydrolase. measurement of activity and use of inhibitors Paton D. M. Methods in Pharmacology. Methods Used in Adenosine Research, Vol. 6:1985;127-145 Plenum Press, New York.
25. Chiang, P. K. (1990) Antiviral activities of 3-deaza nucleosides: indirect inhibitors of methylation. In: Nucleic Acid Methylation, pp. 247-255, Clawson, G. A., Willis, D. B., Weissbach, A. and Jones, P. A. (eds.) Wiley-Liss, New York.
26. Chiang P. K., Cantoni G. L. Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. Biochem. Pharmacol. 28:1979;1897-1902.
27. Chiang P. K., Richards H. H., Cantoni G. L. S-Adenosyl-l-homocysteine hydrolase: analogs of S-adenosyl-l-homocysteine as potential inhibitors Mol. Pharmacol. 13:1977;939-947.
28. Chiang P. K., Cantoni G. L., Bader J. P., Shannon W. M., Thomas J., Montgomery J. A. Adenosylhomocysteine hydrolase inhibitors: synthesis of 5′-deoxy-5′-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus Biochem. Biophys. Res. Commun. 82:1978;417-442.
29. Chiang P. K., Im Y. S., Cantoni G. L. Phospholipids biosynthesis by methylations and choline incorporation: effect of 3-deazaadenosine Biochem. Biophys. Res. Commun. 94:1980;174-181.
30. Chiang P. K., Lucas D. L., Wright D. G. Induction of differentiation of HL-60 human promyelocytic leukemic cells by 3-deazapurines. Ann. NY Acad. Sci. 435:1984;126-128.
31. Chiang, P. K., Brown, N. D., Padilla, F. N. and Gordon, R. K. (1987) Induction of differentiation of 3T3-L1 fibroblasts to adipocytes by 3-deazaadenosine and insulin. In: Tumor Cell Differentiation: Biology and Pharmacology, pp. 241-249, Aarbakke, J., Chiang, P. K. and Koeffler, H. P. (eds.) Humana Press, Clifton.
32. Chiang P. K., Burbelo P. D., Brugh S. A., Gordon R. K., Fukuda K., Yamada Y. Activation of collagen IV gene expression in F9 teratocarcinoma cells by 3-deazaadenosine analogs: indirect inhibitors of methylation J. Biol. Chem. 267:1992;4988-4991.
33. Chiang P. K., Gordon R. K., Tal J., Zeng G. C., Doctor B. P., Pardhasaradhi K., McCann P. P. S-Adenosylmethionine and methylation. FASEB J. 10:1996;471-480.
34. Church M. K., Hughes P. J., Vardey C. J. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br. J. Pharmacol. 87:1986;233-242.
35. Cools M., De Clercq E. Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues in murine L929 cells and their inhibitory effect on L929 cell S-adenosylhomocysteine hydrolase. Biochem. Pharmacol. 38:1989;1061-1067.
36. Cools M., Balzarini J., De Clercq E. Mechanism of antiviral and cytotoxic action of (±)-6′-substituted β-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase. Mol. Pharmacol. 39:1991;718-724.
37. Coulombe R. A., Huie J. M., Sharma R. P., Huggins J. W. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine. Drug Metab. Dispos. 21:1993;555-559.
38. Coulombe R. A., Sharma R. P., Huggins J. W. Pharmacokinetics of the antiviral agent 3-deazaneplanocin A. Eur. J. Drug Metab. Pharmacokinet. 20:1995;197-202.
39. Crooks P. A., Dreyer R. N., Coward J. K. Metabolism of S-adenosylhomocysteine and S-tubercydinylhomocysteine in neuroblastoma cells. Biochemistry. 18:1979;2601-2609.
40. Cui Z., Houweling M., Vance D. E. Suppression of rat hepatoma cell growth by expression of phosphatidylethanolamine N-methyltransferase-2. J. Biol. Chem. 269:1994;24531-24533.
41. De Blas A., Adler M., Shih M., Chiang P. K., Cantoni G. L., Nirenberg M. Inhibitors of CDP-choline synthesis, action potential calcium channels, and stimulus-secretion coupling. Proc. Natl. Acad. Sci. USA. 81:1984;4353-4357.
42. De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob. Agents Chemother. 28:1985;84-89.
43. De Clercq E. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem. Pharmacol. 36:1987;2567-2575.
44. De Clercq E., Bergstrom D. E., Holy A., Montgomery J. A. Broad-spectrum antiviral activity of adenosine analogues. Antiviral Res. 4:1984;119-133.
45. De Clercq E., Cools M., Balzarini J., Marquez V. E., Borcherding D. R., Borchardt R. T., Drach J. C., Kitaoka S., Konno T. Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob. Agents Chemother. 33:1992;1291-1297.
46. De Fazio G., Alba A. P., Vicente M., De Clercq E. Antiviral activity of S-adenosylhomocysteine hydrolase inhibitors against plant viruses. Antiviral Res. 13:1990;219-226.
47. de la Haba G., Agostini S., Bozzi A., Merta A., Unson C., Cantoni G. L. S-Adenosylhomocysteine hydrolase: mechanism of reversible and irreversible inactivation by ATP, cAMP, and 2′deoxyadenosine Biochemistry. 25:1986;8337-8342.
48. Dimock K., Stoltzfus M. Cycloleucine blocks 5′-terminal and internal methylations of avian sarcoma virus genome RNA. Biochemistry. 17:1978;3627-3632.
49. Dudman N. P., Wilcken E. E. Homocysteine thiolactone and experimental homocysteinemia. Biochem. Med. 27:1982;244-253.
50. Eloranta T. O., Kajander E. O. Catabolism and lability of S-adenosyl-l-methionine in rat liver extracts. Biochem. J. 224:1984;137-144.
51. Endresen P. C., Eide T. J., Aarbakke J. Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine. Biochem. Pharmacol. 46:1993;1893-1901.
52. Fabianowska-Majewska K., Duley J. A., Simmonds A. Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver. Biochem. Pharmacol. 48:1994;897-903.
53. Fantone J. C., Duque R. E., Davis B. H., Phan S. H. 3-Deazaadenosine inhibition of stimulus-response coupling in human polymorphonuclear leukocytes. J. Leukocyte Biol. 45:1989;121-128.
54. Finbloom D. S., Marin J., Gordon R. K. Endocytosis of particulate and soluble IgG immune complexes: differential effects of cytoskeletal modulating agents Clin. Exp. Immunol. 67:1987;205-210.
55. Fischer A. A., Müller K., Scholtissek C. Specific inhibition of the synthesis of influenza virus late proteins and stimulation of early, M2, and NS2 protein synthesis by 3-deazaadenosine. Virology. 177:1990;523-531.
56. French J. K., Hurst N. P., Betts W. H. Phorbol 12-myristate 13-acetate, A23187 and l-adrenaline inhibit phospholipid methylation in human monocytes and lymphocytes: inhibition is independent of oxyradical production and phospholipid hydrolysis Free Radic. Biol. Med. 9:1990;271-277.
57. Fuerstein N., Cooper H. L. Studies of the differentiation of promyelocytic cells by phorbol ester. II. A methylation inhibitor, 3-deazaadenosine, inhibits the induction of specific differentiation proteins; lack of effect on early and late phosphorylation Biochem. Biophys. Acta. 781:1984;247-256.
58. Fujioka M. Mammalian small molecule methyltransferases. their structural and functional features Int. J. Biochem. 24:1992;1917-1924.
59. Garcia-Castro I., Mato J. M., Vasanthakumar G., Wiesmann W. P., Schiffmann E., Chiang P. K. Paradoxical effects of adenosine on neutrophil chemotaxis. J. Biol. Chem. 258:1983;4345-4349.
60. Giesler F., Meyer P., Schiffmann D., Wilms K. Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylation. Blut. 58:1989;159-163.
61. Glazer R. I., Knode M. C. Neplanocin A. a cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation J. Biol. Chem. 259:1984;12964-12969.
62. Glazer R. I., Hartman K. O., Knode M. C., Richard M. M., Chiang P. K., Tseng C. K., Marquez V. E. 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60 Biochem. Biophys. Res. Commun. 135:1986;688-694.
63. Glexner C. W., Hildreth J., Kuncl R., Drachman D. 3-Deazaadenosine and inhibition of HIV. Lancet. 339:1992;438.
64. Gordon R. K., Brown N. D., Chiang P. K. Inhibition of adenosylmethionine decarboxylase and perturbation of polyamine metabolism by 3-deaza-(±)aristeromycin. Biochem. Biophys. Res. Commun. 114:1983;505-510.
65. Greenberg M. L., Chaffee S., Hershfield M. S. Basis for resistance to 3-deazaaristeromycin, an inhibitor of S-adeno-sylhomocysteine hydrolase B-lymphoblasts. J. Biol. Chem. 264:1989;795-803.
66. Guranowski A., Jakubowski H. Substrate specificity of S-adenosylhomocysteinase: cysteine is a substrate of the plant and mammalian enzymes Biochim. Biophys. Acta. 742:1983;250-256.
67. Guranowski A., Montgomery J. A., Cantoni G. L., Chiang P. K. Adenosine analogs as substrates and inhibitors of S-adenosylhomocysteine hydrolase. Biochemistry. 20:1981;110-115.
68. Haigler H. T., Gordon R. K., Chiang P. K. Down regulation of epidermal growth (EGF) receptors in the differentiation of 3T3-Ll fibroblasts to fat cells. Ann. NY Acad. Sci. 463:1986;102-104.
69. Harris M. Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell. 29:1982;483-492.
70. Hasboe M., McKee J. G., Borchardt R. T. Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth. Antimicrob. Agents Chemother. 33:1989;828-834.
71. Hoffman J. L. The rate of transmethylation in mouse liver as measured by trapping of S-adenosylhomocysteine. Arch. Biochem. Biophys. 205:1980;132-135.
72. Hohman R. J., Guitton M. C., Veron M. Inactivation of S-adenosyl-l-homocysteine hydrolase by cAMP results from dissociation of enzyme-bound NAD+. Proc. Natl. Acad. Sci. USA. 82:1985;4578-4581.
73. Houston D. M., Dolence E. K., Keller B. T., Patel-Thombre U., Borchardt R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases: 8. Molecular dissection of carbocyclic 3-deazaadenosine as inhibitors of S-adenosylhomocysteine hydrolase J. Med. Chem. 28:1985;467-471.
74. Houston D. M., Dolence E. K., Keller B. T., Patel-Thombre U., Borchardt R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases: 9. 2′,3′-Dialdehyde derivatives of carbocyclic purine nucleosides as potential inhibitors of S-adenosylhomocysteine hydrolase J. Med. Chem. 28:1985;471-477.
75. Hrycyna C. A., Clarke S. Modification of eukaryotic signaling proteins by C-terminal methylation reactions. Pharmacol. Ther. 59:1993;281-300.
76. Huggins J. W., Zhang Z. X., Monath T. P. Inhibition of Ebola virus in vitro in a SCID mouse model by S-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3-deazaneplanocin A. Antiviral Res. (Suppl. 1):1991;122.
77. Hyman B. T., Stoll L. L., Spector A. A. Prostaglandin production by 3T3-L1 cells in culture. Biochim. Biophys. Acta. 713:1982;375-385.
78. Im Y. S., Chiang P. K., Cantoni G. L. Guanidoacetate methyltransferase: purification and molecular properties J. Biol. Chem. 254:1979;11047-11050.
79. Inaba M., Nagashima K., Tsukagoshi S., Sakurai Y. Biochemical mode of cytotoxic action of neplanocin A in L1210 leukemic cells. Cancer Res. 46:1986;1063-1067.
80. Johnson G. S., Chiang P. K. 1-Methylnicotinamide and NAD metabolism in normal and transformed rat kidney cells. Archiv. Biochem. Biophys. 210:1981;263-269.
81. Jurgen C. H., Wolberg G., Zimmerman T. P. Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosine. Agents Actions. 27:1989;398-400.
82. Jurgen C. H., Huber B. E., Zimmerman T. P., Wolberg G. 3-Deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J. Immunol. 144:1990;653-661.
83. Keller B. T., Borchardt R. T. Metabolic conversion of neplanocin A to S-neplanocylmethionine by mouse L 929 cells. Biochem. Biophys. Res. Commun. 120:1984;131-137.
84. Keller B. T., Borchardt R. T. Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells Mol. Pharmacol. 31:1987;485-492.
85. Kim I.-K., Aksamit R. R., Cantoni G. L. Mechanism of the cytostatic activity of 3-deazaaristeromycin, an inhibitor of adenosylhomocysteine hydrolase. J. Biol. Chem. 257:1982;14726-14729.
86. Kim I.-K., Li C.-C., Young H. A., Lee J.-H., Kim H.-S., Pardhasaradhi K., Garcia G. E., Chiang P. K. Apoptosis of L1210 cells induced by 3-deazaadenosine analogs: differential expression of c-myc and NFκB and molecular events J. Biomed. Sci. 4:1997;83-90.
87. Kitade Y., Monguchi Y., Hirota K., Maki Y. Synthesis of a ring-scission analogue of neplanocin A as a potential inhibitor of S-adenosylhomocysteine hydrolase. Tetrahedron Lett. 34:1993;6579-6580.
88. Koch T. K., Gordon A. S., Diamond I. Phospholipid methylation in myogenic cells. Biochem. Biophys. Res. Commun. 114:1983;339-347.
89. Kuncl R. W., Drachman D. B., Adams R., Lehar M. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors J. Pharmacol. Exp. Ther. 267:1993;582-589.
90. Lecompte T., Randon J., Chignard M., Vargaftig B. B., Dray F. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets. Biochem. Biophys. Res. Commun. 106:1982;566-573.
91. Leonard E. J., Skeel A., Chiang P. K., Cantoni G. L. The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes. Biochem. Biophys. Res. Commun. 84:1978;102-109.
92. Liotta L. A., Mandler R., Murano G., Katz D. A., Gordon R. K., Chiang P. K., Schiffmann E. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA. 83:1986;3302-3306.
93. Liteplo R. G. DNA (cytosine) methylation in murine and human tumor cell lines treated with S-adenosylhomocysteine hydrolase inhibitors. Cancer Lett. 39:1988;319-327.
94. Liu S., Wolfe M. S., Borchardt R. T. Rational approaches to the design of antiviral agents based on S-adenosyl-l-homocysteine hydrolase as a molecular target. Antiviral Res. 19:1992;247-265.
95. Lonnechen T., Prytz P. S., Aarbakke J. DNA-methylation in HL-60 cells treated with 3-deaza-(±)-aristeromycin and 3-deazaadenosine. Biochem. Pharmacol. 38:1989;2748-2751.
96. Lonnechen T., Nilsen I. W., Moens U., Andersen A., Aarbakke J. Is there an association between an increase in c-myc RNA steady state levels and c-myc methylation in HL-60 cells treated 3-deaza-(±)-aristeromycin, an indirect inhibitor of methylation. Biochem. Pharmacol. 44:1992;1283-1289.
97. Madhavan G. V., McGee D. P., Rydzewski R. M., Boehme R., Martin J. C., Prisbe E. J. Synthesis and antiviral evaluation of 6′-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase J. Med. Chem. 31:1988;1798-1804.
98. Marquez V. E., Tseng C. K., Kelley J. A., Mitsuya H., Broder S., Roth J. S., Driscoll J. S. 2′,3′-Dideoxy-2′-fuoro-ara-A: an acid-stable purine nucleoside active against human immunodeficiency virus (HIV) Biochem. Pharmacol. 36:1989;2719-2722.
99. Mayers D. L., Mikovits J. A., Bharat H., Hewlett I. K., Estrada J. S., Wolfe A. D., Garcia G. E., Doctor B. P., Burke D. S., Gordon R. K., Lane J. R., Chiang P. K. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs. Increased potency against 3′-azido-3′-deoxythymidine-resistant HIV-1 strains Proc. Natl. Acad. Sci. USA. 92:1995;215-219.
100. 6 cells without affecting membrane fluidity. FEBS Lett. 164:1983;244-246.
101. Medzihradsky J. L., Zimmerman T. P., Wolberg G., Elion G. B. Immunosuppressive effects of the S-adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine. J. Immunopharmacol. 4:1982;29-41.
102. Miura, G. A., Gordon, R. K., Montgomery, J. A. and Chiang, P. K. (1986) 4′-Thioadenosine as a novel inhibitor of S-adenosylhomocysteine hydrolase and an inducer for the differentiation of HL-60 human leukemia cells. In: Purine Metabolism in Man V, Part B, pp. 667-672, Nyhan, W. L., Thompson, L. F. and Watts, R. W. (eds.) Plenum Press, New York.
103. Montgomery J. A. Approaches to antiviral chemotherapy. Antiviral Res. 12:1989;113-132.
104. Montgomery J. A., Clayton S. J., Thomas H. J., Shannon W. M., Arnett G., Bodner A. J., Kim I.-K., Cantoni G. L., Chiang P. K. The carbocyclic analog of 3-deazaadenosine. a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target J. Med. Chem. 25:1982;626-629.
105. Moore J. P., Johannsson A., Hesketh T. R., Smith G. A., Metcalfe J. C. Calcium signals and phospholipid methylation in eukaryotic cells. Biochem. J. 221:1984;675-684.
106. Morita Y., Chiang P. K., Siraganian R. P. Effect of inhibitors of transmethylation on histamine release from human basophils. Biochem. Pharmacol. 30:1981;785-791.
107. Morita Y., Siraganian R. P., Tang C. K., Chiang P. K. The inhibition of histamine release and phosphatidylcholine metabolism by 5′-deoxy-5′-isobutylthio-3-deazaadenosine (3-deaza-SIBA). Biochem. Pharmacol. 31:1982;2111-2113.
108. Mudd S. H., Poole J. R. Labile methyl balances for normal human on various dietary regimens. Metabolism. 24:1975;721-736.
109. Oxenrider K. A., Bu G., Sitz T. O. Adenosine analogs inhibit the guanine-7-methylation of mRNA cap structures. FEBS Lett. 316:1993;273-277.
110. Padel U., Unger C., Söling H. D. Absence of a direct role of phospholipid methylation in stimulus-secretion coupling and control of adenylate cyclase in guinea-pig and rat parotid gland. Biochem. J. 208:1982;205-210.
111. Pankaskie M. C., Kachur J. F., Itoh T., Gordon R. K., Chiang P. K. Inhibition of muscarinic receptor binding and acetylcholine induced contraction of guinea pig ileum by analogs of 5′-isobutylthioadenosine (SIBA). J. Med. Chem. 28:1985;1117-1119.
112. Parry R. J., Muscate A., Askonas L. J. 9-(5′,6′-Dideoxy-β-d-ribo-hex-5′-ynofuranosyl)adenine, a novel inhibitor of S-adenosyl-l-homocysteine hydrolase. Biochemistry. 30:1991;9988-9997.
113. Parry R. J., Muscate A., Herte L. W. Comparison of the inhibition of type A and type B S-adenosyl-l-homocysteine hydrolase: effects of cofactor content on inhibition behavior and nucleoside binding J. Enzyme Inhib. 8:1995;243-253.
114. Patil S. D., Schneller S. W., Hosoya M., Snoeck R., Andrei G., Balzarini J., De Clercq E. Synthesis of antiviral properties of (±)-5′-noraristeromycin and related purine carbocyclic nucleosides: a new lead for anti-human cytomegalovirus agent design J. Med. Chem. 35:1992;3372-3377.
115. Phyall W., Chiang P. K., Cantoni G. L., Lovenberg W. The hypotensive action of 3-deazaadenosine. Eur. J. Pharmacol. 67:1980;485-488.
116. Pike M. C., DeMeester C. A. Inhibition of phosphoinositide metabolism in human polymorphonuclear leukocytes by S-adenosylhomocysteine. J. Biol. Chem. 263:1988;3592-3599.
117. Prakash N. J., Davis G. F., Jarvi E. T., Edwards M. L., McCarthy J. R., Bowlin T. Antiviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase. Life Sci. 50:1992;1425-1435.
118. Pritchard P. H., Chiang P. K., Cantoni G. L., Vance D. E. Inhibition of phosphatidylethanolamine N-methylation by 3-deazaadenosine stimulates the synthesis of phosphatidylcholine via the CDP-choline pathway. J. Biol. Chem. 257:1982;6362-6367.
119. Prus K. L., Wolberg G., Keller P. M., Fyfe J. A., Stopford C. R., Zimmerman T. P. 3-Deazaadenosine 5′-triphosphate. a novel metabolite of 3-deazaadenosine in mouse leukocytes Biochem. Pharmacol. 38:1989;509-517.
120. Prytz P. S., Aarbakke J. Differential cell cycle perturbation by transmethylation inhibitors. Biochem. Pharmacol. 39:1990;203-206.
121. 2 by transmethylation inhibitors. Biochem. Pharmacol. 42:1991;1761-1766.
122. Pugh C. S., Borchardt R. T. Effects of S-adenosyl-homocysteine analogues on vaccinia viral messenger ribonucleic acid synthesis and methylation. Biochemistry. 21:1982;1535-1541.
123. Rabe C. S., Williams T. P., McGee R. Jr. Enhancement of depolarization-dependent release of norepinephrine by an inhibitor of S-adenosylhomocysteine-dependent transmethylations. Life Sci. 27:1980;1753-1759.
124. Randon J., Touqui L., Wal F., LeCompte T., Dray F., Vargaftig B. B. Mechanisms of platelet activation: role of methylation reactions Weissmann G. Advances in Inflammation Research, Vol. 8. 1984;165-181 Raven Press, New York.
125. Ransohoff R. M., Narayan P., Ayers D. F., Rottman F. M., Nilsen T. W. Priming of influenza mRNA transcription is inhibited in CHO cells treated with the methylation inhibitor, neplanocin A. Antiviral Res: 7:1987;317-327.
126. Richards H. H., Chiang P. K., Cantoni G. L. Adenosylhomocysteine hydrolase: crystallization of the purified enzyme and its properties J. Biol. Chem. 253:1978;4476-4480.
127. Riches D. W., Watkins J. L., Henson P. M., Stanworth D. R. Regulation of macrophage lysosomal secretion by adenosine, adenosine phosphate esters, and related structural analogues of adenosine. J. Leukocyte Biol. 37:1985;545-557.
128. Robert-Géro M., Berneman A. DNA methylase activity associated with Rous sarcoma virus. FEBS Lett. 89:1978;33-36.
129. Robert-Géro M., Lawrence F., Farrugia G., Berneman A., Blanchard P., Vigier P., Lederer E. Inhibition of virus-induced cell transformation by synthetic analogues of S-adenosyl homocysteine. Biochem. Biophys. Res. Commmun. 65:1975;1242-1249.
130. Rush J. S., Sweitzer T., Kent C., Decker G. L., Waechter C. J. Biogenesis of the endoplasmic reticulum in activated B lymphocytes: temporal relationships between the induction of protein N-glycosylation activity and the biosynthesis of membrane protein and phospholipid Arch. Biochem. Biophys. 284:1991;63-70.
131. Saunders P. P., Tan M.-T., Robins R. K. Metabolism and action of neplanocin A in Chinese hamster ovary cells. Biochem. Pharmacol. 34:1985;2749-2754.
132. Scarpa S., Strom R., Bozzi A., Aksamit R. A., Backlund P. S. Jr., Chen J., Cantoni G. L. Differentiation of myoblast cell lines and biological methylation: 3-deazaadenosine stimulates formation of multinucleated myofibers Proc. Natl. Acad. Sci. USA. 81:1984;3064-3068.
133. Schanche J.-S., Ogreid D., Koskeland S. O., Refsnes M., Sand T. E., Ueland P. M., Christoffersen T. Evidence against a requirement for phospholipid methylation in adenylate cyclase activation by hormones. FEBS Lett. 138:1982;167-172.
134. Schanche J.-S., Schanche T., Ueland P. M., Holy A., Votruba I. The effect of aliphatic adenine analogues on S-adenosylhomocysteine hydrolase in intact hepatocytes. Mol. Pharmacol. 26:1984;553-558.
135. Schmidt J. A., Bomford R., Gao X.-M., Rhodes J. 3-Deazaadenosine: an inhibitor of interleukin 1 production by human peripheral blood monocytes Int. J. Immunopharmacol. 12:1990;89-97.
136. Schneller S. W., Thompson R. D., Cory J. G., Olsson R. A., De Clercq E., Kim I.-K., Chiang P. K. Biological activity and a modified synthesis of 8-amino-3-β-d-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycin. J. Med. Chem. 27:1984;924-928.
137. Seeley P. J., Rukenstein A., Connolly J. L., Greene L. A. Differential inhibition of nerve growth factor and epidermal growth factor effects on the PC12 pheochromocytoma line. J. Cell Biol. 98:1984;417-426.
138. Shanker R., de la Motte C. A., DiCorleto P. E. 3-Deazaadenosine inhibits thrombin-stimulated platelet-derived growth factor production and endothelial-leukocyte adhesion molecule-1-mediated monocytic cell adhesion in human aortic endothelial cells. J. Biol. Chem. 267:1992;9376-9382.
139. Shattil S. J., Montgomery J. A., Chiang P. K. The effect of pharmacological inhibition of phospholipid methylation on human platelet function. Blood. 59:1982;906-912.
140. Shealy Y. F., Clayton J. D. Synthesis of carbocyclic analogs of purine ribonucleosides. J. Am. Chem. Soc. 91:1969;3075-3083.
141. Sherman M. L., Shafman T. D., Spriggs D. R., Kufe D. W. Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine. Cancer Res. 45:1985;5830-5834.
142. Shuto S., Obara T., Saito Y., Toriya M., Hosoya M., Snoeck R., Andrei G., Balzarini J., De Clercq E. New neplanocin analogues: 1. Synthesis of 6′-modified neplanocin A derivatives as broad-spectrum antiviral agents J. Med. Chem. 35:1992;324-331.
143. Shuto S., Obara T., Itoh H., Kosugi Y., Saito Y., Toriya M., Yaginuma S., Shigeta S., Matsuda A. New neplanocin analogues: III. 6′ R-configuration is essential for the antiviral activity of 6′-C-methyl-3-deazaneplanocin A's Bioorg. Med. Chem. Lett. 4:1994;605-608.
144. Shuto S., Obara T., Itoh H., Kosugi Y., Saito Y., Toriya M., Yaginuma S., Shigeta S., Matsuda A. New neplanocin analogues: IV. An adenosine deaminase-resistant equivalent of neplanocin A Chem. Pharm. Bull. 42:1994;1688-1690.
145. Shuto S., Obara T., Saito Y., Andrei G., Snoeck R., De Clercq E., Matsuda A. New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6′-homoneplanocin A. J. Med. Chem. 39:1996;2392-2399.
146. Siddiqi S. M., Chen X., Rao J., Schneller S. W., Satoru I., Snoeck R., Andrei G., Balzarini J., De Clercq E. 3-Deaza- and 7-deaza-5′-noraristeromycin and their antiviral properties. J. Med. Chem. 38:1992;1035-1038.
147. Smejkal R. M., Abalis I., Pankaskie M. C., Chiang P. K. Muscarinic receptor subtype specificity of 5′-(isobutylthio)-adenosine (SIBA) and its analogs. Gen. Pharmacol. 20:1989;385-392.
148. Smith D. M., Johnson J. A., Turner R. A. Biochemical perturbations of BW 91Y (3-deazaadenosine) on human neutrophil chemotactic potential and lipid metabolism. Int. J. Tissue React. 13:1991;1-18.
149. Smith J. D., Ledoux D. N. Effect of the methylation inhibitors 3-deazaadenosine and 3-deazaaristeromycin on phosphatidylcholine formation in Tetrahymena. Biochim. Biophys. Acta. 1047:1990;290-293.
150. Smolenski R. T., Montero C., Duley J. A., Simmonds H. A. Effects of adenosine analogues on ATP concentrations in human erythrocytes. Biochem. Pharmacol. 42:1991;1767-1773.
151. Stoltzfus C. M., Montgomery J. A. Selective inhibition of avian sarcoma virus protein synthesis in 3-deaazadenosine-treated infected chicken embryo fibroblasts. J. Virol. 38:1981;173-183.
152. Stopford C. R., Wolberg G., Prus K. L., Reynolds-Vaughn R., Zimmerman T. P. 3-Deazaadenosine-induced disorganization of macrophage microfilaments. Proc. Natl. Acad. Sci. USA. 82:1985;4060-4064.
153. Sung S.-S., Silverstein S. C. Inhibition of macrophage phagocytosis by methylation inhibitors: lack of correlation of protein carboxymethylation and phospholipid methylation with phagocytosis J. Biol. Chem. 260:1985;546-554.
154. Szyf M. The DNA methylation machinery as a target for anticancer therapy. Pharmacol. Ther. 70:1996;1-37.
155. Touqui L., Chignard M., Wal F., Vargaftig B. B. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets. Experientia. 40:1984;374-377.
156. Trager W., Tershakovec M., Chiang P. K., Cantoni G. L. Plasmodium falciparum: antimalarial activity in culture of sinefungin and other methylation inhibitors Exp. Parasitol. 50:1980;83-89.
157. Tseng C. K., Marquez V. E., Fuller R. W., Goldstein B. M., Haines D. R., McPherson H., Parsons J. L., Shannon W. M., Arnett G., Hollingshead M., Driscoll J. S. Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 32:1989;1442-1446.
158. Van Phi L., Söling H.-D. Methyl group transfer from exogenous S-adenosylmethionine on to plasma-membrane phospholipids without cellular uptake in isolated hepatocytes. Biochem. J. 206:1982;481-487.
159. Vedel M., Robert-Géro M., Legraverend M., Lawrence F., Lederer E. Inhibition of tRNA methylation in vitro and in whole cells by an oncostatic S-adenosyl-homocysteine (SAH) analogue: 5′-deoxy 5′-S-isobutyl adenosine (SIBA) Nucl. Acids Res. 5:1978;2979-2989.
160. Verhoeven G., Cailleau J., De Clercq E. Stimulatory effects of antiviral adenosine analogs on steroidogenesis in Leydig cells. J. Steroid Biochem. 31:1988;267-274.
161. Villalón M. D., Gil-Fernández C., De Clercq E. Activity of several S-adenosylhomocysteine hydrolase inhibitors against African swine fever virus replication in Vero cells. Antiviral Res. 20:1993;131-144.
162. Vogel U., Kunerl M., Scholtissek C. Influenza A virus late mRNAs are specifically retained in the nucleus in the presence a methyltransferase or a protein kinase inhibitor. Virology. 198:1994;227-233.
163. Whaun J. M., Miura G. A., Brown N. D., Gordon R. K., Chiang P. K. Antimalarial activity of neplanocin A with perturbations in the metabolism of purines, polyamines and S-adenosylmethionine. J. Pharmacol. Exp. Ther. 236:1986;277-283.
164. White E. L., Shaddix S. C., Brockman R. W., Bennett L. L. Jr. Comparison of the actions of 9-β-d-arabinofuranosyl-2-fluoroadenine and 9-β-d-arabinofuranosyladenine on target enzymes from mouse tumor cells. Cancer Res. 42:1982;2260-2264.
165. Wiesmann W. P., Johnson J. P., Miura G. A., Chiang P. K. Aldosterone stimulated transmethylations are linked to sodium transport. Am. J. Physiol. 248:1985;f43-f47.
166. Wnuk S.F., Yuan C.-S., Borchardt R. T., Balzarini J., De Clercq E. Nucleic acid related compounds. 84 Synthesis of. 6′-(E and Z):1994;3579-3587.
167. 1 cells J. Biol. Chem. 261:1986;4492-4498.
168. Wolos J. A., Frondorf K. A., Davis G. F., Jarvi E. T., McCarthy J. R., Bowlin T. L. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-l-homocysteine hydrolase. J. Immunol. 150:1993;3264-3273.
169. Woyciniuk P., Linder M., Scholtissek C. The methyltransferase inhibitor neplanocin A interferes with influenza virus replication by a mechanism different from that of 3-deazaadenosine. Virus Res. 35:1995;91-99.
170. Wyde P. R., Ambrose M. W., Meyer H. L., Zolinski C. L., Gilbert B. E. Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rat. Antiviral Res. 14:1990;215-226.
171. Yagawa K., Nakanishi M., Hayashi S., Kaku M., Ichinose Y., Itoh T., Tomoda A., Yoneyama Y., Shigematsu N. Abolishment of inhibitory effects of 3′-deazaadenosine on superoxide generation of guinea pig phagocytes by pre-exposure to phorbol myristate acetate. FEBS Lett. 201:1986;287-290
172. Yaginuma S., Muto N., Tsujino N., Sudate Y., Hayashi M., Otani M. Studies on neplanocin A, new antitumor antibiotic: I. Producing organism, isolation and characterization J. Antibiot. 34:1981;359-366.
173. Zeng, G. C., Dave, J. R. and Chiang, P. K. (1997) Induction of protooncogenes during 3-deazaadenosine-stimulated differentiation of 3T3-L1 fibroblasts to adipocytes: mimicry of insulin action. Oncol. Res., in press.
174. Zimmerman T. P., Deeprose R. D., Wolberg G., Duncan G. S. Metabolic formation of nucleoside-modified analogues of S-adenosylmethionine. Biochem. Biophys. Res. Commun. 91:1979;997-1004.
175. Zimmerman T. P., Deeprose R. D., Wolberg G., Duncan G. S. Potentiation by homocysteine of adenosine-stimulated elevation of cellular adenosine 3′,5′-monophosphate. Biochem. Pharmacol. 28:1979;2375-2379.
176. Zimmerman T. P., Schmitges C. J., Deeprose R. D., Wolberg G., Duncan G. S. Inhibition of cyclic AMP phosphodiesterase by 5′deoxy-5′-S-isobutylthioadenosine at biologically active concentrations of drug. Life Sci. 28:1979;647-652.
177. Zimmerman T. P., Schmitges C. J., Wolberg G., Deeprose R. D., Duncan G. S., Cuatrecasas P., Elion G. Modulation of cyclic AMP metabolism by S-adenosylhomocysteine hydrolase and S-3-deazaadenosylhomocysteine in mouse lymphocytes. Proc. Natl. Acad. Sci. USA. 77:1980;5639-5643.
178. Zimmerman T. P., Iannone M., Wolberg G. 3-Deazaadenosine: S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes J. Biol. Chem. 260:1984;546-554.